Epimède Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3

- Investments
-
17
- Portfolio
-
7
- Exits
-
3

Epimède General Information
Description
Founded in 2015, Epimède is a venture capital firm based in Liège, Belgium. The firm seeks to invest in the life sciences, engineering services, and corporate services sectors.
Contact Information
Website
www.epimede.com
Year Founded
2015
Investor Status
Actively Seeking New Investments
Trade Association
Belgian Venturing Association (BVA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- Rue Lambert-Lombard 3 à
- 4000 Liege
- Belgium
+32 04 000 00 00
Epimède Investments (17)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Laser Cheval | 05-Sep-2022 | Buyout/LBO | Machinery (B2B) | Generating Revenue | ||
00000 | 15-Mar-2022 | 00 000000000 | 000.00 | Machinery (B2B) | Generating Revenue | |
000000000 | 17-Nov-2021 | 00000 00000 | 00.000 | Decision/Risk Analysis | Generating Revenue | 0000 0000000 |
000000 | 03-Feb-2021 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | |
0000 00000 0000000 | 19-Jan-2021 | 00000 00000 | 00.00 | Surgical Devices | Generating Revenue | 00000000 000000 |
0000000 | 15-Jul-2019 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | |
000000 | 18-Jun-2019 | 00000 00000 | 000.00 | Drug Discovery | Clinical Trials - Phase 2 | 0000 000000 |
0000 00000 0000000 | 18-Oct-2018 | 00000 00000 | 00.000 | Surgical Devices | Generating Revenue | 00000000 000000 |
Radiomics | 01-Feb-2018 | Early Stage VC | 00.000 | Decision/Risk Analysis | Generating Revenue | 0000000 000000000 00.0 |
Ncardia | 17-Nov-2017 | Later Stage VC | 000.00 | Biotechnology | Generating Revenue | 0000 0000000 |
Epimède Exits (3)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Diagenode | 01-Mar-2021 | Merger/Acquisition | 00000 |
0000 00000 0000000 | 30-May-2017 | 000000000000000000 | |
0000 0000000 | 11-May-2016 | 000 | 000.00 |
Epimède Investments by Industry, Year, and Region
Epimède Team (3)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Philippe Degeer | Co-Founder & Investment Manager | 0 | Liege, Belgium | ||
Bernard Surlemont Ph.D | Executive, Management Team | 0 | 0 | Liege, Belgium | |
Marc Foidart | Co-Founder & Investment Manager | 00 | 0 | 0 | Liege, Belgium |
Epimède Co-Investors (14)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Federal Holding and Investment Company | 3 | 0 |
![]() |
![]() |
|
Noshaq | 0 | 0 |
![]() |
![]() |
|
Société Régionale d'Investissement de Wallonie | 0 | 0 |
![]() |
![]() |
|
EQT Life Sciences | 0 | 0 |
![]() |
![]() |
|
Pfizer ( Pharmaceuticals) | 0 | 0 |
![]() |
![]() |